Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121852) titled 'Comparison of Anticoagulant Efficacy of Different Doses of Nafamostat Mesylate in Continuous Renal Replacement Therapy (CRRT) in the ICU' on April 3.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhujiang Hospital of Southern Medical University
Condition:
Severe cases requiring CRRT treatment
Intervention:
Low-dose group:Anticoagulation for CRRT using nafamostat at an initial dose of 20 mL/h
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-03
Target Sample Size: Low-dose group:46;High-dose group:46;
Countries of Recruitment:
China
To know...